moxie
Selected indexed studies
- Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). (Ann Neurol, 2021) [PMID:33068037]
- Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension. (Mov Disord, 2023) [PMID:36444905]
- Moxie begets MOXI: The journey to a novel hypothesis about Mu-opioid and OXytocin system Interactions. (Compr Psychoneuroendocrinol, 2024) [PMID:39104824]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). (2021) pubmed
- Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension. (2023) pubmed
- Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data. (2024) pubmed
- Moxie begets MOXI: The journey to a novel hypothesis about Mu-opioid and OXytocin system Interactions. (2024) pubmed
- New insights into chronic inducible urticaria. (2024) pubmed
- Chronic Inducible Urticaria. (2024) pubmed
- Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment. (2024) pubmed
- Gut microbiota facilitate chronic spontaneous urticaria. (2024) pubmed
- Physical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management. (2023) pubmed
- Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus. (2025) pubmed